======= TNFRSF13B ======= == Gene Information == * **Official Symbol**: TNFRSF13B * **Official Name**: TNF receptor superfamily member 13B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23495|23495]] * **UniProt**: [[https://www.uniprot.org/uniprot/O14836|O14836]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TNFRSF13B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TNFRSF13B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604907|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Receptor for TNFSF13/APRIL and TNFSF13B/TALL1/BAFF/BLYS that binds both ligands with similar high affinity. Mediates calcineurin-dependent activation of NF-AT, as well as activation of NF-kappa-B and AP-1. Involved in the stimulation of B- and T- cell function and the regulation of humoral immunity. {ECO:0000269|PubMed:10956646, ECO:0000269|PubMed:10973284}. |TACI-CRD2| |negative regulation of B cell proliferation| |B cell homeostasis| |negative regulation of B cell activation| |lymphocyte homeostasis| |regulation of B cell proliferation| |leukocyte homeostasis| |negative regulation of lymphocyte proliferation| |negative regulation of mononuclear cell proliferation| |negative regulation of leukocyte proliferation| |hematopoietic progenitor cell differentiation| |tumor necrosis factor-mediated signaling pathway| |negative regulation of lymphocyte activation| |negative regulation of leukocyte activation| |negative regulation of cell activation| |homeostasis of number of cells| |signaling receptor activity| |regulation of B cell activation| |regulation of lymphocyte proliferation| |regulation of mononuclear cell proliferation| |regulation of leukocyte proliferation| |cellular response to tumor necrosis factor| |response to tumor necrosis factor| |negative regulation of immune system process| |regulation of lymphocyte activation| |hemopoiesis| |regulation of leukocyte activation| |hematopoietic or lymphoid organ development| |adaptive immune response| |regulation of cell activation| |immune system development| |cytokine-mediated signaling pathway| |negative regulation of cell population proliferation| |cellular response to cytokine stimulus| |response to cytokine| |integral component of plasma membrane| |regulation of cell population proliferation| |homeostatic process| |regulation of immune system process| |immune response| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11542 * **Expression level (log2 read counts)**: 2.28 {{:chemogenomics:nalm6 dist.png?nolink |}}